BCIQ Profiles

Company Profile Report
0520 QTs
BioCentury & Getty Images


May 20 Quick Takes: RNA play Haya closes CHF18 million seed round; plus DualityBio, RenBio, BioTheryX and more

May 20, 2021 | 8:16 PM GMT

Swiss biotech Haya Therapeutics S.A. joins a growing group of RNA-focused newcos raising early venture rounds with a CHF 18 million ($20 million) seed round led by Broadview Ventures to develop therapeutics targeting long non-coding RNAs

Read the full 624 word article

How to gain access

Continue reading with a
two-week free trial.